GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
105.69
+8.80 (9.08%)
At close: Apr 23, 2025, 4:00 PM
106.00
+0.31 (0.29%)
After-hours: Apr 23, 2025, 6:09 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.97 billion as of April 23, 2025. Its market cap has increased by 1,039.77% in one year.
Market Cap
2.97B
Enterprise Value
2.94B
1-Year Change
1,039.77%
Ranking
Category
Stock Price
$105.69
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.97B, a decrease of -83.43%. That is a compound annual growth rate of -33.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 2.72B | 28.80% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |